The earnings call presented a mix of achievements, such as the successful launch of the Nexa system and growth in specific product segments, countered by challenges like declining services revenue, slower overall sales growth, and margin pressures. The outlook includes cautious optimism with expectations of growth driven by new product launches, but also acknowledges ongoing uncertainties in key markets.

Company Guidance

In the Cochlear Limited FY '25 results presentation, CEO Diggory William Howitt highlighted key financial metrics and strategic directions amidst lower-than-expected sales. Despite a modest 4% revenue growth, the company prioritized R&D investment, which has consistently increased year-on-year, to sustain its market leadership and innovation, such as the 20-year development of the Nexa system, the world's first smart cochlear implant. The presentation underscored a 9% growth in cochlear implant revenue, with significant gains in emerging markets, while services revenue faced a 10% decline due to various factors including the cost of living pressures in the U.S. For FY '26, Cochlear anticipates 11%-17% reported net profit growth, driven by strong developed market performance on the back of the Nexa launch, while facing headwinds from volume-based pricing in China. The company remains committed to long-term growth with strategic pricing and product enhancements despite current profitability variabilities.

Launch of Nexa System

Introduction of the world's first smart cochlear implant, Nexa, developed over 20 years with advanced features like Smart Sync for seamless processor replacement and future potential for diagnostics and neural health assessment.

Growth in Cochlear Implants

Cochlear implant revenue grew by 9% with a 12% increase in systems sold. Strong growth was observed particularly in emerging markets with over 20% increase.

Acoustics Segment Growth

Acoustics segment revenue increased by 6%, driven by a 30% growth in Osia products.

Advancements in R&D

Continued investment in R&D to support long-term growth, with plans for further development of drug-eluting electrodes and other innovations.

Cochlear (AU:COH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

AU:COH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 18, 2026	2026 (Q2)	3.15 / -	3.14	―	―	―
Aug 14, 2025	2025 (Q4)	2.95 / 2.84	2.964	-4.25% (-0.13)
Feb 13, 2025	2025 (Q2)	3.10 / 3.14	2.925	7.35% (+0.22)
Aug 14, 2024	2024 (Q4)	3.11 / 2.96	2.491	18.99% (+0.47)
Feb 18, 2024	2024 (Q2)	2.86 / 2.92	2.15	36.05% (+0.77)
Aug 14, 2023	2023 (Q4)	2.45 / 2.49	1.82	36.87% (+0.67)
Feb 14, 2023	2023 (Q2)	2.11 / 2.15	2.4	-10.42% (-0.25)
Aug 18, 2022	2022 (Q4)	1.83 / 1.82	1.69	7.69% (+0.13)	―	―
Feb 21, 2022	2022 (Q2)	2.01 / 2.40	1.91	25.65% (+0.49)	―	―
Aug 19, 2021	2021 (Q4)	2.74 / 1.69	0.35	382.86% (+1.34)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

AU:COH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 14, 2025	AU$305.99	AU$309.03	+0.99%
Feb 13, 2025	AU$302.11	AU$260.63	-13.73%
Aug 14, 2024	AU$332.63	AU$308.25	-7.33%
Aug 14, 2023	AU$226.75	AU$239.65	+5.69%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cochlear Limited (AU:COH) report earnings?

Cochlear Limited (AU:COH) is schdueled to report earning on Feb 18, 2026, TBA (Confirmed).

What is Cochlear Limited (AU:COH) earnings time?

Cochlear Limited (AU:COH) earnings time is at Feb 18, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Cochlear Limited stock?

The P/E ratio of Cochlear is N/A.

What is AU:COH EPS forecast?

AU:COH EPS forecast for the fiscal quarter 2026 (Q2) is 3.15.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing